| UniProt ID | ACTZ_HUMAN | |
|---|---|---|
| UniProt AC | P61163 | |
| Protein Name | Alpha-centractin | |
| Gene Name | ACTR1A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 376 | |
| Subcellular Localization | Cytoplasm, cytoskeleton . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cell cortex . | |
| Protein Description | Component of a multi-subunit complex involved in microtubule based vesicle motility. It is associated with the centrosome.. | |
| Protein Sequence | MESYDVIANQPVVIDNGSGVIKAGFAGDQIPKYCFPNYVGRPKHVRVMAGALEGDIFIGPKAEEHRGLLSIRYPMEHGIVKDWNDMERIWQYVYSKDQLQTFSEEHPVLLTEAPLNPRKNRERAAEVFFETFNVPALFISMQAVLSLYATGRTTGVVLDSGDGVTHAVPIYEGFAMPHSIMRIDIAGRDVSRFLRLYLRKEGYDFHSSSEFEIVKAIKERACYLSINPQKDETLETEKAQYYLPDGSTIEIGPSRFRAPELLFRPDLIGEESEGIHEVLVFAIQKSDMDLRRTLFSNIVLSGGSTLFKGFGDRLLSEVKKLAPKDVKIRISAPQERLYSTWIGGSILASLDTFKKMWVSKKEYEEDGARSIHRKTF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Sulfoxidation | -------MESYDVIA -------CCCCCEEC | 7.52 | 28465586 | |
| 1 | Acetylation | -------MESYDVIA -------CCCCCEEC | 7.52 | 22223895 | |
| 3 | Phosphorylation | -----MESYDVIANQ -----CCCCCEECCC | 25.90 | 46158779 | |
| 4 | Phosphorylation | ----MESYDVIANQP ----CCCCCEECCCC | 10.83 | 26552605 | |
| 18 | Phosphorylation | PVVIDNGSGVIKAGF CEEEECCCCEEECCC | 35.82 | 27251275 | |
| 22 | Ubiquitination | DNGSGVIKAGFAGDQ ECCCCEEECCCCCCC | 39.80 | - | |
| 32 | Ubiquitination | FAGDQIPKYCFPNYV CCCCCCCCCCCCCCC | 57.17 | - | |
| 32 | Acetylation | FAGDQIPKYCFPNYV CCCCCCCCCCCCCCC | 57.17 | 30586733 | |
| 33 | Phosphorylation | AGDQIPKYCFPNYVG CCCCCCCCCCCCCCC | 8.25 | 29496907 | |
| 34 | S-nitrosylation | GDQIPKYCFPNYVGR CCCCCCCCCCCCCCC | 5.96 | 21278135 | |
| 34 | S-nitrosocysteine | GDQIPKYCFPNYVGR CCCCCCCCCCCCCCC | 5.96 | - | |
| 38 | Phosphorylation | PKYCFPNYVGRPKHV CCCCCCCCCCCCCCC | 12.43 | 29496907 | |
| 43 | Ubiquitination | PNYVGRPKHVRVMAG CCCCCCCCCCCCEEC | 54.06 | - | |
| 48 | Sulfoxidation | RPKHVRVMAGALEGD CCCCCCCEECCEECC | 1.67 | 21406390 | |
| 66 | Methylation | GPKAEEHRGLLSIRY CCCHHHCCCCEEEEC | 40.51 | - | |
| 72 | Methylation | HRGLLSIRYPMEHGI CCCCEEEECCCCCCC | 26.57 | - | |
| 73 | Phosphorylation | RGLLSIRYPMEHGIV CCCEEEECCCCCCCC | 12.78 | 28509920 | |
| 75 | Sulfoxidation | LLSIRYPMEHGIVKD CEEEECCCCCCCCCC | 4.38 | 30846556 | |
| 81 | Ubiquitination | PMEHGIVKDWNDMER CCCCCCCCCHHHHHH | 55.92 | 21906983 | |
| 96 | Ubiquitination | IWQYVYSKDQLQTFS HHHHHCCHHHHHCCC | 31.63 | 21890473 | |
| 171 | Phosphorylation | VTHAVPIYEGFAMPH CEEEEEEECCCCCCC | 12.15 | 82491 | |
| 200 | Acetylation | FLRLYLRKEGYDFHS HHHHHHHHCCCCCCC | 53.55 | 26051181 | |
| 200 | Ubiquitination | FLRLYLRKEGYDFHS HHHHHHHHCCCCCCC | 53.55 | 21890473 | |
| 230 | Acetylation | YLSINPQKDETLETE EEECCCCCCCCHHCE | 59.81 | 23954790 | |
| 230 | Malonylation | YLSINPQKDETLETE EEECCCCCCCCHHCE | 59.81 | 26320211 | |
| 230 | Ubiquitination | YLSINPQKDETLETE EEECCCCCCCCHHCE | 59.81 | - | |
| 238 | Ubiquitination | DETLETEKAQYYLPD CCCHHCEECEEECCC | 48.48 | 21890473 | |
| 293 | Phosphorylation | SDMDLRRTLFSNIVL CCHHHHHHHHHCEEE | 26.22 | 20071362 | |
| 296 | Phosphorylation | DLRRTLFSNIVLSGG HHHHHHHHCEEECCC | 28.85 | 24719451 | |
| 301 | Phosphorylation | LFSNIVLSGGSTLFK HHHCEEECCCCHHHC | 30.16 | 22199227 | |
| 304 | Phosphorylation | NIVLSGGSTLFKGFG CEEECCCCHHHCCHH | 26.01 | 22199227 | |
| 305 | Phosphorylation | IVLSGGSTLFKGFGD EEECCCCHHHCCHHH | 39.22 | 22199227 | |
| 308 | Ubiquitination | SGGSTLFKGFGDRLL CCCCHHHCCHHHHHH | 57.34 | 2190698 | |
| 313 | Methylation | LFKGFGDRLLSEVKK HHCCHHHHHHHHHHH | 37.60 | - | |
| 319 | Ubiquitination | DRLLSEVKKLAPKDV HHHHHHHHHHCCCCC | 37.71 | - | |
| 319 | Malonylation | DRLLSEVKKLAPKDV HHHHHHHHHHCCCCC | 37.71 | 26320211 | |
| 331 | Phosphorylation | KDVKIRISAPQERLY CCCEEEEECCHHHHH | 24.85 | 23312004 | |
| 338 | Phosphorylation | SAPQERLYSTWIGGS ECCHHHHHCCCHHHH | 15.41 | 31136907 | |
| 363 | Phosphorylation | MWVSKKEYEEDGARS HHCCHHHHCCCCCCC | 33.23 | 29496907 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ACTZ_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ACTZ_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACTZ_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NUMA1_HUMAN | NUMA1 | physical | 10504299 | |
| DCTN2_HUMAN | DCTN2 | physical | 22939629 | |
| PRS6B_HUMAN | PSMC4 | physical | 22939629 | |
| MYH9_HUMAN | MYH9 | physical | 22939629 | |
| PSMD1_HUMAN | PSMD1 | physical | 22939629 | |
| RRS1_HUMAN | RRS1 | physical | 22939629 | |
| MCM7_HUMAN | MCM7 | physical | 22939629 | |
| ARP10_HUMAN | ACTR10 | physical | 12857853 | |
| ARP10_HUMAN | ACTR10 | physical | 22863883 | |
| LMNB1_HUMAN | LMNB1 | physical | 22863883 | |
| MYCBP_HUMAN | MYCBP | physical | 22863883 | |
| NU133_HUMAN | NUP133 | physical | 22863883 | |
| DCTN1_HUMAN | DCTN1 | physical | 26344197 | |
| DCTN2_HUMAN | DCTN2 | physical | 26344197 | |
| DCTN5_HUMAN | DCTN5 | physical | 26344197 | |
| PACN3_HUMAN | PACSIN3 | physical | 26344197 | |
| RPB4_HUMAN | POLR2D | physical | 26344197 | |
| DCTN2_HUMAN | DCTN2 | physical | 27173435 | |
| DCTN1_HUMAN | DCTN1 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |